Carl Zeiss Meditec reported €262.6 million in revenue in the first quarter of the fiscal year compared with €241.1 million reported in the same quarter of the previous fiscal year, according to a press release. Revenue in the Surgical Ophthalmology strategic business unit was reported at €92.6 million in the first quarter, a 13.6% increase from €81.6 million in the same quarter of the previous year.
Wide range of treatments available to optimize ocular surface
The lid margin plays an important role in maintaining ocular surface health. Inflammation of the lid margin in the form of anterior or posterior blepharitis can cause ocular surface inflammation and degrade the quality of the tear film. Before any elec…
Ophthotech Corporation to Report Fourth Quarter 2015 Financial Results and Host Conference Call on Wednesday, February 24, 2016
NEW YORK–(BUSINESS WIRE)–Ophthotech announced that it will report its fourth quarter and year ended December 31, 2015 financial results on Wednesday, February 24, 2016.
FDA Issues Guidance to Protect Blood Supply From Zika Virus
The FDA recommendations are more expansive than safeguards announced earlier this month by the American Red Cross. Medscape Medical News
CMS Releases Core Quality Measures
(MedPage Today) — Aimed at reducing administrative burdens on physicians
Study shows possible genetic link to persistent retinal fluid in AMD
MIAMI — Persistent retinal fluid in eyes that have been treated with anti-VEGFs for neovascular age-related macular degeneration may have a genetic basis, a speaker told colleagues here.“Here we are, basically 10 years after anti-VEGF was introduced, and we’re seeing where the unmet needs are. Only 30%, a third of patients, who are treated gain three lines of vision. That would have been amazing 10 years ago, but we want more. About a third of patients also have persistent fluid after 1 year of treatment,” Philip J. Rosenfeld, MD, PhD, said at Angiogenesis, Exudation, and Degeneration 2016.